Mylan finalizes $465 million EpiPen settlement

The drug manufacturer will pay $465 million for overcharging the US government for the EpiPen.

DHcNh5lWAAAOj8I.jpg

H2
H3
H4
3 columns
2 columns
1 column
Join the conversation now
Logo
Center